相关实验视频

Updated: Jul 10, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

FOXO1,一种微小的蛋白质,具有复杂的相互作用:在肺癌中是一个有希望的治疗候选者

Mohammad Ebrahimnezhad¹, Mohammad Natami², Ghazaleh Hafezi Bakhtiari³

¹Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|November 19, 2023

概括

叉头盒O1 (FOXO1) 是肺癌中的关键瘤抑制剂,调节细胞循环停止和亡等过程. 向FOXO1可能为克服耐药性和治疗晚期肺癌提供新的策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

肺癌仍然是全球癌症死亡的主要原因之一.
尽管有针对性的疗法,肺癌的进展和耐药性仍然是临床的主要挑战.
了解分子机制对于开发新型治疗策略至关重要.

研究的目的:

审查转录因子FOXO1在肺癌中的作用.
探索在肺癌中调节FOXO1的信号通路和分子机制.
讨论FOXO1在药物耐药性的参与及其作为治疗点的潜力.

主要方法:

文献综述侧重于FOXO1在肺癌中的功能.
对参与FOXO1调节的分子机制和信号通路的分析.
对影响FOXO1.1的当前药理化合物的检查.

主要成果:

在肺癌中,FOXO1充当瘤抑制剂,影响细胞循环停止,细胞亡,DNA修复和化学抵抗.
包括FOXO1在内的转录因子的失调在恶性瘤中很常见.
FOXO1在癌症发育和治疗相关的细胞过程中发挥着关键作用.

结论:

FOXO1是肺癌药物发现的重要治疗标.
刺激FOXO1及其调节剂可能为治疗耐药或晚期肺癌提供策略.
需要进一步的临床前研究来评估针对FOXO1.1的组合药物策略.

关键词:

这就是FOXO1的意义.肺癌是一种肺癌.它们是ncRNAs.信号通道的信号通道.转录因子转录因子

更多相关视频

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...